Literature DB >> 15167696

Putative association of polymorphism in the mannose 6-phosphate receptor gene with major depression and Alzheimer's disease.

Heike Kölsch1, Ursula Ptok, Michael Majores, Sandra Schmitz, Marie Luise Rao, Wolfgang Maier, Reinhard Heun.   

Abstract

The endosomal lysosomal system might play a role in Alzheimer's disease, but its impact in major depression is unknown. The expression of the cation-dependent mannose 6-phosphate receptor (CD-MPR) is increased in Alzheimer's disease and the CD-MPR gene is located next to a region on chromosome 12 possibly linked to Alzheimer's disease. We investigated a C/T polymorphism in the CD-MPR gene in 188 Alzheimer's disease patients, in a control sample of 193 patients with major depression, as hospitalized controls, and in 259 healthy controls. We examined the interaction of the CD-MPR polymorphism with the putative risk factor for Alzheimer's disease, the cathepsin D T-allele. No significant association of the CD-MPR C-allele with Alzheimer's disease was observed. However, exploratory data analysis revealed an increased frequency of the CD-MPR C-allele in patients with major depression; thus, the C-allele may be a risk factor for depression. Gene location and function of the CD-MPR suggest an involvement in Alzheimer's disease; however, we could not find an association of the CD-MPR polymorphism with Alzheimer's disease. Since exploratory data suggest an involvement of the endosomal lysosomal system in major depression, further studies are warranted to investigate the biological role of the CD-MPR in major depression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15167696     DOI: 10.1097/01.ypg.0000129204.58574.c2

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  1 in total

1.  Lack of association between cathepsin D C224T polymorphism and Alzheimer's disease risk: an update meta-analysis.

Authors:  Cuiju Mo; Qiliu Peng; Jingzhe Sui; Jian Wang; Yan Deng; Li Xie; Taijie Li; Yu He; Xue Qin; Shan Li
Journal:  BMC Neurol       Date:  2014-01-15       Impact factor: 2.474

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.